NCRI’s third strategic plan stating our goals for 2012–2017…
Management of locally advanced pancreatic cancer (LAPC) workshop
'This was an excellent meeting with a comprehensive programme covering many aspects of locally advanced pancreatic cancer (LAPC) treatment. The aim was to bring together experts in the field to look at current treatment, in particular the role of radiotherapy, for pancreatic cancer and the way forward so that the newly funded SCALOP II and the proposed ESPAC 5 are able to maximise improvement in pancreatic cancer treatment in the next few years. …
Radiotherapy Research Trials in the UK: Secrets of Success
'One in three people will develop cancer and around half of these will be treated with radiotherapy, with most receiving radical treatment with curative intent (http://globocan.iarc.fr/factsheets/cancers/all.asp). However, conducting randomised controlled trials addressing radiotherapy questions can be challenging. This editorial will explore solutions to optimise the success of radiotherapy trials, with reference to lung and breast radiotherapy studies.…
Is spending on proton beam therapy for cancer going too far, too fast?
'Rapid Response to BMJ article: Is spending on proton beam therapy for cancer going too far, too fast?…
CTRad Biomarker workshop
'The aim of this workshop was to deliver the positive findings of basic radiobiology research more quickly and efficiently into clinical trials, and ultimately from there to deliver improved medical practice where there is the need to introduce top quality translational research (TR) into phase I, II & III radiotherapy (RT) clinical trials. …
Tumour site reviews of drug-radiotherapy combinations, Soft tissue sarcoma
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Tumour site reviews of drug-radiotherapy combinations, Prostate cancer
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Tumour site reviews of drug-radiotherapy combinations, Pancreatic cancer
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Tumour site reviews of drug-radiotherapy combinations, Head and neck cancer
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Tumour site reviews of drug-radiotherapy combinations, Glioma
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Tumour site reviews of drug-radiotherapy combinations, Breast cancer
'In 2010–2011, CTRad produced a suite of tumour site reviews, highlighting the opportunity for specific agents to be combined with radiotherapy in preclinical or clinical studies.…
Radiotherapy Research Priorities for the UK
'Radiotherapy research in the UK has become a priority among the major research funders who are partners of the National Cancer Research Institute (NCRI).…